FMC Corporation Announces New Thailand Microcrystalline Cellulose Manufacturing Facility
PHILADELPHIA, July 24, 2012 – FMC Corporation (NYSE:FMC) today announced the company will invest more than $100 million in a new world class microcrystalline cellulose (MCC) manufacturing facility in Rayong, Thailand. The new plant will ensure the company’s long-term ability to supply the growing Asia market with its industry leading Avicel® colloidal MCC.
“Today’s announcement represents another major step in FMC’s Vision 2015 growth strategy,” said Pierre Brondeau, FMC president, CEO, and chairman. “This significant investment underscores FMC’s continuing commitment to profitably grow our signature product lines, and to introduce or broaden the availability of leading FMC technologies in rapidly growing regions.”
The new facility, expected to come on line in the fourth quarter 2014, will increase FMC’s global food grade MCC capacity by 35 percent. The Thailand facility will initially manufacture Avicel® colloidal MCC, which is widely used as a key ingredient in food and beverages. However, the facility’s design will allow for future volume expansion, and the manufacture of different product lines for both the food and pharmaceutical markets, as demand warrants.